TABLE 3.
Specimen | Dilution tested | NucliSens HIV-1 QT (copies/ml)
|
NASBA HIV-1 RNA QT (copies/ml) | ||
---|---|---|---|---|---|
Lot 1 | Lot 2 | Lot 3 | |||
9040321 | Undiluted | 470,000 (5.67) | 340,000 (5.53) | 470,000 (5.67) | 360,000 (5.56) |
1:300 | 2,500 (3.40) | 1,200 (3.08) | 1,700 (3.23) | 2,000 (3.30) | |
1:3,000 | 81 (1.91) | 150 (2.18) | 41 (1.61) | <LDLb | |
1:30,000 | <Lower limitc | <Lower limit | <Lower limit | <LDL | |
9040423 | Undiluted | 200,000 (5.30) | 92,000 (4.96) | 170,000 (5.23) | 240,000 (5.38) |
1:100 | 2,100 (3.32) | 1,200 (3.08) | 1,600 (3.20) | 3,900 (3.59) | |
1:1,000 | 270 (2.43) | 81 (1.91) | 470 (2.67) | <LDL | |
1:10,000 | <Lower limit | <Lower limit | <Lower limit | <LDL | |
9040318 | Undiluted | 73,000 (4.86) | 38,000 (4.58) | 82,000 (4.91) | 84,000 (4.92) |
1:100 | 910 (2.96) | 580 (2.76) | 360 (2.56) | 1,300 (3.11) | |
1:1,000 | 42 (1.62) | <Lower limit | 120 (2.08) | <LDL | |
1:10,000 | <Lower limit | <Lower limit | <Lower limit | <LDL | |
9040338 | Undiluted | 13,000 (4.12) | 6,300 (3.80) | 6,800 (3.83) | 16,000 (4.20) |
1:10 | 950 (2.98) | 790 (2.90) | 1,200 (3.08) | 1,100 (3.04) | |
1:100 | 35 (1.54) | <Lower limit | <Lower limit | <LDL | |
1:1,000 | <Lower limit | <Lower limit | <Lower limit | <LDL | |
9040500 | Undiluted | 4,400 (3.64) | 2,800 (3.45) | 7,800 (3.89) | 6,600 (3.82) |
1:5 | 950 (2.98) | 760 (2.88) | 1,300 (3.12) | 1,100 (3.04) | |
1:50 | 200 (2.30) | 28 (1.45) | 360 (2.56) | <LDL | |
1:500 | <Lower limit | <Lower limit | <Lower limit | <LDL | |
9040428 | Undiluted | 4,000 (3.60) | 2,000 (3.30) | 3,700 (3.57) | 3,700 (3.57) |
1:5 | 740 (2.87) | 190 (2.28) | 500 (2.70) | 1,200 (3.08) | |
1:20 | 280 (2.45) | 130 (2.11) | <Lower limit | <LDL | |
1:200 | <Lower limit | <Lower limit | <Lower limit | <LDL |
Values in parentheses are log10 HIV-1 copies/ml.
<LDL, result below the detectable limit for NASBA HIV-1 QT (400 copies/ml).
Below lower limit for NucliSens HIV-1 QT (25 copies/ml).